Progress in the Chemistry of Organic Natural Products Vol. 94 [recurso electrónico] / edited by A. Douglas Kinghorn, Heinz Falk, Junichi Kobayashi.

Por: Kinghorn, A. Douglas [editor.]Colaborador(es): Falk, Heinz [editor.] | Kobayashi, Junichi [editor.] | SpringerLink (Online service)Tipo de material: TextoTextoSeries Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products ; 94Editor: Vienna : Springer Vienna : Imprint: Springer, 2011Descripción: XVIII, 254 p. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783709107485Tema(s): Chemistry | Chemistry, Organic | Chemistry | Organic ChemistryFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 547 Clasificación LoC:QD415-436Recursos en línea: Libro electrónicoTexto En: Springer eBooksResumen: The three reviews cover the advances in the chemistry and biology of withanolides over the last 16 years, review the chemistry and biology of the rocaglamide-type derivatives and related compounds, with emphasis on their structural diversity, biosynthesis, pharmacological significance and total synthesis, and summarize the extensive chemistry and biology studies on a natural product, which have resulted in a novel therapy approved worldwide.
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos QD415 -436 (Browse shelf(Abre debajo)) 1 No para préstamo 377001-2001

The three reviews cover the advances in the chemistry and biology of withanolides over the last 16 years, review the chemistry and biology of the rocaglamide-type derivatives and related compounds, with emphasis on their structural diversity, biosynthesis, pharmacological significance and total synthesis, and summarize the extensive chemistry and biology studies on a natural product, which have resulted in a novel therapy approved worldwide.

19

Con tecnología Koha